目的探讨一种治疗肝硬化门脉高压症的术式。
Objective to search for an operation method which can treat hepatocirrhosis and portal hypertension.
目的胆管手术合并肝硬化门脉高压症的临床研究。
Objective To study bile duct operation and portal hypertension.
探讨强肝软坚方对肝硬化门脉高压症的作用及其可能机制。
To study the effect of Qianggan Ruanjian decoction (QRD) on hepatocirrhosis portal hypertension and its possible function mechanism.
目的：探讨肝硬化门脉高压时腹壁下动、静脉超声图像特征。
Purpose: To detect and analyze blood flow changes in inferior epigastric artery and vein as well as the ultrasound imaging characteristics in patients with portal hypertension.
方法对13例肝硬化门脉高压患者行pto治疗，然后进行PSE。
Methods PTO is applied to treat 13 portal hypertension patients with cirrhosis, then PSE is applied.
目的：探讨甲氰咪胍对肝硬化门脉高压症犬门脉血液动力学的影响。
Objective To investigate the effects of Cimetidine on portal hemodynamics in dogs with cirrhosis and portal hypertension.
目的：研究肝硬化门脉高压血清NO水平与血流动力学改变之间的关系。
Objective: To explore the relationship between the plasma level of NO and the hyperdynamic circulation of cirrhotic patients with portal hypertension.
方法回顾性分析本中心23例肝脏移植肝硬化门脉高压症患者的临床资料。
Methods Clinical data of 23 patients with portal hypertension who underwent orthotropic liver transplantation (OLT) were studied retrospectively.
目的：分析肝硬化门脉高压电子束ct血管造影表现，探讨其临床应用价值。
Objective: to analyze electron beam ct angiography characteristics of portal hypertension in liver cirrhosis and to investigate its value of clinical application.
结论脾大部切除脾大网膜腹膜后固定术是治疗肝硬化门脉高压症的一种理想术式。
Conclusion It is an ideal operation method in the treatment of hepatocirrhosis and portal hypertension.
目的 ：比较丹参、硝苯啶联用与各药单用治疗肝硬化门脉高压症的血流动力学变化。
Objective:To compare the effects of salvia and nifedipine on hemodynamics in patients with liver cirrhosis and portal hypertension by using doppler ultrasound.
目的：探讨光量子血氧疗法（UBIO）在肝硬化门脉高压症术后肝损伤治疗中的应用。
Objective: To study the effect of ultraviolet blood irradiation and oxygenation(UBIO)on liver trauma after operation for symptom of hepatocirrhosis portal hypertension.
结论检测肝硬化门脉高压症患者的肝组织NO含量、NOS活性可预测其肝脏损伤程度。
Detecting the level of NO and the activity of NOS of patients with hepatic portal hypertension can predict the degree of liver injury.
方法：在肝硬化门脉高压症行脾切除，断流术的同时制作一腹膜管，使腹水经此管转流于皮下。
Method To make a peritoneum canal at the meantime splenectomy and cut off stream, the ascites flow in the subdermal via the peritoneum.
观察ho 1及CO系统在肝硬化大鼠不同时期的表达，以探讨其在肝硬化门脉高压中的作用。
Observation was made on the expression of HO-1 and CO system in different periods of hepatic cirrhosis in rats.
④不论是正常还是肝硬化门脉高压症大鼠脾脏都具有免疫功能，应视具体情况尽可能保留脾脏。
These findings indicate that either in the normal or in the cirrhosis rats the spleen works functionally and should be preserved as far as possible according to its actual situation.
方法收集124例肝硬化门脉高压症住院患者的资料，对照分析导致出血的诱因，总结预见性护理方法。
Methods There were 124 cases of portal hypertension patients, comparative analysis with the bleeding factors and sum up the methods of the predictive nursing.
方法：将72例肝硬化门脉高压食管胃底静脉出血患者分为善宁组和垂体后叶素组，进行临床疗效的对比观察。
Methods 72 patients suffered from bleeding in gastroesophageal varices for cirrhosis were divided into two groups, and clinical effect of Sandostatin and Vasopressin were measured respectively.
目的观察HO CO系统在肝硬化病人肝组织中的表达及与门静脉压力的关系，以探讨其在肝硬化门脉高压中的作用。
Purpose To observe the relationship between portal pressure and the expression of HO-CO system in liver of patients with hepatic cirrhosis and the effect on portal hypertension in hepatic cirrhosis.
目的探讨肝硬化门脉高压患者血浆一氧化氮(NO)和内皮素1 (et - 1)水平与食管静脉曲张和腹水的关系。
Objective To study the relationship between plasma levels of nitric oxide (NO) and endothelin-1 (ET-1) levels and the esophagus varices, ascites in cirrhotic patients with portal hypertension.
材料与方法：对22例临床确诊的肝硬化门脉高压患者行WHVP测定，测量WHVP及肝静脉压力梯度(HVPG)。
Materials and Methods: WHVP and hepatic venous pressure gradient (HVPG) were measured in 22 patients with the cirrhotic portal hypertension.
结果发现：肝硬化门脉高压患者门脉系统动、静脉属支皆处于高血流状态，门脉主干的淤血指数较正常人高，门脉系统动脉属支阻力指数均较正常人低。
We found that there were high blood flow states in the arterial and the veinous branches of the portal vein system. There were higher congestion in…
静息性的肝硬化可能在出现因门脉高压引起的充血性脾肿大导致的无症状的血小板减少症之后才被发现。
Silent cirrhosis may be discovered after the finding of asymptomatic thrombocytopenia caused by the congestive splenomegaly of portal hypertension .
结果肝硬化消化性溃疡的发生率为14 92 % ，门脉高压性胃病的发生率为43 75 % ；
Results The incidence of peptic ulcer in cirrhosis patients was 14.92%, and portal hypertensive gastrosis was 43.75%.
结论：利用MRI的特殊序列和检查方法在肝硬化和门脉高压早期诊断中有重要价值。
Conclusion: MRI special sequences and methods play a significant role in the early diagnosis of liver cirrhosis and portal hypertension.
目的探讨门静脉营养在治疗肝硬化、门脉高压症中的作用。
Objective To explore the effects of portal nutrition on liver cirrhosis and portal hypertension.
目的：通过核磁共振成像（MRI）的特殊序列和检查方法，评价MRI在肝硬化和门脉高压早期诊断中的作用。
Objective: To evaluate the diagnostic value of the special sequences and methods of MRI in liver cirrhosis and portal hypertension.
目的：探讨肝硬化、门脉高压症行脾切除术后早期应用抗凝药物对预防门静脉血栓的意义。
Objective To research the anticoagulants in protecting the portal vein obstruction after splenectomy due to the portal hypertension of hepatic cirrhosis.
《国际肝病》：门脉高压及其并发症如静脉曲张出血，腹水和肝性脑病在肝硬化患者较常见。
International Digest: Portal hypertension and its complications such as variceal hemorrhage, ascites, and encephalopathy are common in cirrhosis.
病人患有肝硬化和门脉高压症，很可能会发生肝性胸水，最常见的是右侧单侧胸腔积液。
The diagnosis of hepatic hydrothorax should be suspected in a patient with established cirrhosis and portal hypertension, presenting with a unilateral pleural effusion, most commonly right-sided.
应用推荐